Jerusalem, Israel
Jerusalem, Israel

The Hebrew University of Jerusalem is Israel's second-oldest university, after the Technion. The Hebrew University has three campuses in Jerusalem and one in Rehovot. The world's largest Jewish studies library is located on its Edmond J. Safra Givat Ram campus.The first Board of Governors included Albert Einstein, Sigmund Freud, Martin Buber, and Chaim Weizmann. Four of Israel's prime ministers are alumni of the Hebrew University. In the last decade, seven researchers and alumni of the University received the Nobel Prize and one was awarded the Fields Medal.According to the Academic Ranking of World Universities, the Hebrew University is the top university in Israel, overall the 59th-best university in the world, 16th in mathematics, 27th in computer science and 44th in business/economics.In 2013, the Center for World University Rankings ranked the Hebrew University 21st in the world and the top in Israel in its World University Rankings, while another survey ranked it as the 9th best university to work in, and the 2nd best outside of the United States. Wikipedia.


Time filter

Source Type

Patent
Oneday Biotech And Pharma Ltd. and Hebrew University of Jerusalem | Date: 2017-01-25

The present invention relates to potent compounds having combined antioxidant, antiinflammatory, anti-radiation and metal chelating properties. Specifically, the present invention relates to short peptides having said properties, and to methods and uses of such short peptides in clinical and cosmetic applications.


Patent
Hebrew University of Jerusalem | Date: 2017-03-08

A system for characterizing a plant is disclosed. The system comprises: a plurality of sensors configured to sense a first parameter indicative of a transpiration rate from the whole plant and a second parameter indicative of a water uptake rate into the whole plant. The system also comprises a processor configured to receive signals from the sensors, to process the signals to calculate both the parameters, and to characterize the plant according to the calculated parameters. In some embodiments of the present invention the processor is configured for calculating at least one of the first parameter and the second parameters momentarily.


The present invention relates to kits, arrays, compositions and methods for predicting, assessing and evaluating responsiveness and success of interferon treatment as well as for monitoring disease progression and pathophysiology in a subject treated with interferon, using OAS2, HERC5, UPS18, UBE2L6 and optionally of ISG15 genes as biomarkers.


Patent
Hebrew University of Jerusalem and Qlight Nanotech Ltd. | Date: 2017-02-08

A polarized light source configured for use in display device and backlight unit is described. The polarized light source comprising: at least one optically active structure comprising a plurality of nanorods configured to emit light of one or more wavelengths in response to exciting pumping field, said plurality of nanorods comprising nanorods aligned with a predetermined alignment axis so as to produce a desired polarization direction of the emitted light; and a light directing assembly comprising one or more optical elements in optical path of light emitted from the light emitting structure, said light directing assembly being configured to enhance output of the emitted light from the emitting structure while substantially maintaining the polarization of the emitted light passing therethrough. Preferably, layers associated with the polarized light source are aligned with parallel principal axes.


Patent
Hebrew University of Jerusalem | Date: 2017-03-15

The invention provides a process for treating a soil contaminated with a pollutant selected from the group consisting of petroleum products and aromatic hydrocarbons, comprising bringing into contact with said soil an aqueous solution in which hydrogen peroxide and hydroxide source are combined.


Patent
Hebrew University of Jerusalem and Hadasit Medical Research Services And Development | Date: 2017-02-22

A method of detecting death of a cell type or tissue in a subject is disclosed. The method comprises determining whether cell-free DNA comprised in a fluid sample of the subject is derived from the cell type or tissue, wherein the determining is effected by ascertaining the methylation status of at least four methylation sites on a continuous sequence of the cell-free DNA, the sequence comprising no more than 300 nucleotides, wherein a methylation status of each of the at least four methylation sites on the continuous sequence of the DNA characteristic of the cell type or tissue is indicative of death of the cell type or tissue. Kits for detecting cell death are also disclosed.


Patent
Hebrew University of Jerusalem and Qlight Nanotech Ltd. | Date: 2017-05-03

The present invention provides an optically active structure and the use thereof in a backlight unit. The optically active structure comprises a plurality of optically active particles configured to emit light of one or more predetermined wavelength range in response to pumping energy, and a plurality of light scattering elements. The plurality of light scattering elements comprises optically transparent void regions, such as void regions surrounding filler particles.


Patent
Hebrew University of Jerusalem | Date: 2017-05-24

Peptide-based neurokinin antagonists of fish reproduction are disclosed. Compositions comprising antagonists of fish neurokinin and methods of inhibiting or delaying puberty, fish maturation or reproduction processes using these compounds are also provided.


Patent
Ben - Gurion University of the Negev and Hebrew University of Jerusalem | Date: 2017-05-31

The present invention provides a composite of graphene oxide and PTZ that may further entrap a redox enzyme. This composite can be used for detecting the substrate of the redox enzyme in a sample or for producing an acid byproduct of the enzymatic reaction. Furthermore, provided herein is a kit which includes a composite of graphene oxide and PTZ entrapping a redox enzyme and means for connecting the entrapping composite to a source of electricity.


Atlas D.,Hebrew University of Jerusalem
Annual Review of Biochemistry | Year: 2013

Transmitter release is a fast Ca2+-dependent process triggered in response to membrane depolarization. It involves two major calcium-binding proteins, the voltage-gated calcium channel (VGCC) and the vesicular protein synaptotagmin (syt1). Ca2+ binding triggers transmitter release with a time response of conformational changes that are too fast to be accounted for by Ca2+ binding to syt1. In contrast, conformation-triggered release, which engages Ca2+ binding to VGCC, better accounts for the fast rate of the release process. Here, we summarize findings obtained from heterologous expression systems, neuroendocrine cells, and reconstituted systems, which reveal the molecular mechanism by which Ca2+ binding to VGCC triggers exocytosis prior to Ca2+ entry into the cell. This review highlights the molecular aspects of an intramembrane signaling mechanism in which a signal is propagated from the channel transmembrane (TM) domain to the TM domain of syntaxin 1A to trigger transmitter release. It discusses fundamental problems of triggering transmitter release by syt1 and suggests a classification of docked vesicles that might explain synchronous transmitter release, spontaneous release, and facilitation of transmitter release. © 2013 by Annual Reviews. All rights reserved.

Loading Hebrew University of Jerusalem collaborators
Loading Hebrew University of Jerusalem collaborators